Search - tctmd.com

Displaying 1 - 20 of 51

Sort: Relevancy | Date

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

News Features

AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts

Michael O'Riordan

February 19, 2025

News Conference News AHA 2024

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Shelley Wood

November 18, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

Presentation TCT 2024

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Presenter: Raymond Townsend

October 29, 2024

Presentation TCT 2024

Debate Con: RDN Will Ultimately Be a Niche Therapy

Presenter: Andrew Sharp

October 29, 2024

Presentation TCT 2024

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

Presenter: Michael Weber

October 29, 2024

Presentation TCT 2024

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

Presenter: Michael Bloch

October 29, 2024

Presentation TCT 2024

What Evaluation is Required for Patient Selection for RDN?

Presenter: Naomi Fisher

October 29, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Conference News ACC 2021

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Michael O'Riordan

May 18, 2021

Presentation TCT 2020

TCT ID 7: Everolimus-Eluting Stent vs Bare-Metal Stent in ST-Segment Elevation Myocardial Infarction – 10-Year Follow-up of the Multicentre Randomized Controlled Examination Trial

Presenter: Salvatore Brugaletta

October 15, 2020

Presentation TCT 2020

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presenter: Michael Megaly

October 15, 2020

Presentation TCT 2020

TCT ID 5: Six-Month and One-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study

Presenter: Robert Smith

October 15, 2020

Presentation TCT 2020

TCT ID 3: Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention – Insights From REDUCE-IT PCI

Presenter: Benjamin Peterson

October 15, 2020

Advertisement

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Debate Con: RDN Will Ultimately Be a Niche Therapy

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

What Evaluation is Required for Patient Selection for RDN?

What’s Going to Be Big at TCT 2024?

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

What’s Going to Be Hot at AHA 2023

What’s Going to Be Hot at TCT 2023

What’s Going to Be Hot at ESC 2022?

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

TCT ID 7: Everolimus-Eluting Stent vs Bare-Metal Stent in ST-Segment Elevation Myocardial Infarction – 10-Year Follow-up of the Multicentre Randomized Controlled Examination Trial

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

TCT ID 5: Six-Month and One-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study

TCT ID 3: Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention – Insights From REDUCE-IT PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content